Chris Garabedian

Xontogeny is a biotech aggregator that seeks to accelerate the development of life science technologies.

Raised $15,000,000.00 from Perceptive Advisors.

Perceptive Advisors is a privately owned hedge fund sponsor that finances the public equity markets across the globe.

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

Raised $50,000,000.00 from Perceptive Advisors, Hibiscus Capital Management, Rapha Capital Management, Barer & Son Capital, Perceptive Advisors and Rapha Capital Management.

CereVasc is a medical device company focused on improving the treatment of patients with hydrocephalus.

Raised $114,000,000.00 from Bain Capital Life Sciences and Perceptive Advisors.

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Raised $330,000,000.00 from Drive Capital and Aisling Capital.

BCG Securities focuses on wealth management with high net worth individuals.

Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.

Raised $1,385,962,933.00 from Michael Andrew Chambers and Roche Financial.